MedTrace Logo

Mindfulness-based Interventions in COPD Patients

NCT04769505 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-03-18

No results posted yet for this study

Summary

The purpose of this pilot study is to assess the feasibility of a brief digital mindfulness-based intervention for COPD patients and its effectiveness regarding the reduction of psychological distress as well as stress.

Conditions

  • Chronic Obstructive Pulmonary Disease Exacerbation

Interventions

BEHAVIORAL

digital mindfulness-based intervention (MBI)

The digital MBI consists of four auditory guided mindfulness exercises lasting between 10 and 15 minutes. The four exercises are a body scan and three sitting meditations (awareness of the heartbeat, awareness of the body, awareness of sounds). The exercises can be conducted via a software (https://www.movisens.com/de/produkte/movisensxs/) on participants' smartphones. Participants will be familiarized with the concept of mindfulness and the intervention in a single face-to-face introductory session. Additionally, participants will receive a manual, containing all relevant information. Participants will be instructed to practice at least once daily over the course of eight weeks. We recommended to come up with a fixed time point for the mindfulness practice to facilitate a routine. They can choose individually between the exercises. After the intervention period, participants received the exercises as audio files and could continue practicing.

Sponsors & Collaborators

  • University of Vienna

    collaborator OTHER

  • Klinik Ottakring

    collaborator UNKNOWN

  • Klinik Floridsdorf

    collaborator UNKNOWN

  • Therme Wien Med (Ambulant Pulmonary Rehabilitation)

    collaborator UNKNOWN

  • Karl Landsteiner Institute for Lung Research and Pneumological Oncology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-12-05
Completion
2023-03-27

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04769505 on ClinicalTrials.gov